Bausch Health Patents – Insights & Stats

Bausch Health has a total of 10722 patents globally, out of which 4888 have been granted. Of these 10722 patents, more than 21% patents are active. United States of America is where Bausch Health has filed the maximum number of patents, followed by Europe and Japan. Parallelly, United States of America seems to be the main focused R&D centre and Canada is the origin country of Bausch Health.

Bausch Health was founded in the year 1959. The Company discovers and distributes pharmaceutical. The Company develops drugs for unmet medical needs in central nervous system disorders, eye health and gastrointestinal diseases, as well as contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetic devices. As of April 2023, the market cap of Bausch Health is $2.93 Billion.

Do read about some of the most popular patents of Bausch Health which have been covered by us in this article and also you can find Bausch Health patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Bausch Health patent portfolio.

How many patents does the founder and the CEO of Bausch Health have?

The founder Milan Panic has 2 patents and CEO Thomas J. Appio has 0 patent.

How many patents does Bausch Health have?

Bausch Health has a total of 10722 patents globally. These patents belong to 2378 unique patent families. Out of 10722 patents, 2304 patents are active.

How Many Patents did Bausch Health File Every Year?

Bausch Health Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantBausch Health Applications FiledBausch Health Patents Granted
2023112
20223984
20218179
2020117126
2019103107
201871142
201772191
2016115174
201564168
2014190248
2013327341
2012270389

Which Bausch Health Drug Patents are Expiring in the Next 10 Years?

The patent no. US9662394B2 which is expiring in Oct, 2034, this invention offers stable compositions for treating fungal infections, including efinaconazole, butylated hydroxytoluene, a salt of ethylenediaminetetraacetic acid, and optional citric acid.

Given below is the list of few drugs patented by Bausch Health accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.

Drug NamePatent NumberPatent TitlePatent Expiration
JubliaUS9662394B2Stabilized Efinaconazole CompositionsOct, 2034
ZyclaraUS8299109B2Method Of Treating Actinic Keratosis…Dec, 2029
SolodynUS7919483B2Method For The Treatment Of AcneMar, 2027
AplenzinUS7572935B2Modified Release Formulations Of…Jun, 2026
AcanyaUS10220049B2Topical Pharmaceutical Formulations…Jun, 2029

How many Bausch Health patents are Alive/Dead?

Bausch Health Patent Portfolio

 How Many Patents did Bausch Health File in Different Countries?

Bausch Health Worldwide Patent Filing

Countries in which Bausch Health Filed Patents

CountryPatents
United States Of America1957
Europe1047
Japan737
Australia598
Germany591
Canada577
China548
Spain433
Korea (South)364
Hong Kong (S.A.R.)362
Mexico261
Brazil222
India213
Singapore201
Austria201
Taiwan171
Poland122
Argentina80
South Africa78
Denmark53
New Zealand49
Indonesia49
Portugal46
United Kingdom46
Israel45
Hungary44
Russia42
Norway38
Malaysia38
Italy36
Slovenia26
Croatia23
Cyprus20
Czech Republic16
Chile15
Costa Rica14
Peru12
Slovakia11
Serbia10
Yugoslavia/Serbia and Montenegro9
Philippines9
Malta9
Georgia9
Ecuador8
Colombia8
Ukraine7
Ireland7
Uruguay5
Nicaragua5
France4
Bolivia4
Turkey4
Viet Nam4
Saudi Arabia4
Dominican Republic4
Lithuania3
Eurasia3
Panama2
Belize2
Tunisia2
Finland2
Uzbekistan2
Latvia2
Luxembourg2
Albania2
Montenegro2
Macao2
Iceland2
Africa1
Switzerland1
United Arab Emirates1
Netherlands1
Greece1
Morocco1
Belgium1
Gulf Cooperation Council1
Africa1

Where are Research Centres of Bausch Health Patents Located?

R&D Centers of Bausch Health

10 Best Bausch Health Patents

US6413255B1 is the most popular patent in the Bausch Health portfolio. It has received 1211 citations so far from companies like Standen, Thermage and Cardima.

Below is the list of 10 most cited patents of Bausch Health:

Publication NumberCitation Count
US6413255B11211
US8180458B21028
US6350276B1880
US6358263B2761
US8142200B2736
US6430446B1664
US6425912B1608
US6749624B2552
US20040206365A1518
US6381498B1510

How many inventions of other companies were rejected due to Bausch Health patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Bausch Health invention. They couldn’t because Bausch Health had protected those before them.

Examiners at the USPTO referred 780 Bausch Health patents in 4120 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Bausch Health patent portfolio are Alcon, Bank of New York and Barclays Bank.

List of the Companies whose Patents were rejected citing Bausch Health –

CompanyNumber of Patent Applications that faced Rejection Citing Bausch Health PatentsNumber of Rejections (102 & 103)
Alcon108296
Bank of New York76253
Barclays Bank56140
Johnson & Johnson Vision Care54146
Amo Development2748
Carl Zeiss Meditec2270
Syneron Medical2061
Philips1949
Novartis1843
Katalyst Surgical1835

Count of 102 and 103 Type Rejections based on Bausch Health Patents

 Top Bausch Health Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US6413255B135
US20040206365A122
US7241805B220
US7390089B220
US20050049582A119
US8475507B217
US8426457B216
US9492272B214
US7282060B214
US7130835B214
US8579887B213
US20100055133A113
US7006874B213
US8702691B212
US6572608B112

What Percentage of Bausch Health US Patent Applications were Granted?

Bausch Health (Excluding its subsidiaries) has filed 748 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 647 have been granted leading to a grant rate of 93.77%.

Below are the key stats of Bausch Health patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Bausch Health?

Law FirmTotal ApplicationsSuccess Rate
Bausch & Lomb Incorporated24298.31%
Thompson HineBausch8987.65%
Mccarter & English8575.32%
Bausch Health Kilpatrick Townsend & Stockton7998.44%
Saul Ewing Arnstein & Lehr45100.00%
Hse Valeant2187.50%
Oblon Mcclelland Maier & Neustadt16100.00%
Valeant Pharmaceuticals International1090.00%
Bass Berry & Sims962.50%
Michael E Carmen9100.00%

What are Bausch Health key innovation segments?

What Technologies are Covered by Bausch Health?

The chart below distributes patents filed by Bausch Health in different countries on the basis of the technology protected in patents. It also represents the markets where Bausch Health thinks it’s important to protect particular technology inventions.

R&D Focus: How has Bausch Health search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Bausch Health Patents?

Related Articles

Rapoo Patents – Insights & Stats (Updated 2024)

Rapoo has a total of 562 patents globally, out of which 507 have been granted. Of these 562 patents, more than 31% patents are active. China is where Rapoo has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, China seems to be

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.